个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib

| 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Wang, Y.[1] * ; Wang, L.[1] ; Zuo, J.[1] ; Feng, L.[1] ; Fan, Z.[1] ; Zhang, X.[1] ; Han, J.[1] ; Zhou, X.[1] ; Li, B.[2] ; Su, N.[2] ; Du, H.[2] ; Zhou, J.[2] ;
机构： [1]Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang/CN, [2]Burning Rock Biotech, Guangzhou/CN
出处：
ISSN：

关键词： metastasis EGFR mutations non-small cell lung cancer

语种：
外文
WOS：
中科院分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang/CN,
推荐引用方式(GB/T 7714)：
Wang Y.,Wang L.,Zuo J.,et al.The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(3):S420-S421.
APA：
Wang, Y.,Wang, L.,Zuo, J.,Feng, L.,Fan, Z....&Zhou, J..(2021).The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib.JOURNAL OF THORACIC ONCOLOGY,16,(3)
MLA：
Wang, Y.,et al."The Prognostic Value of Metastasis to Different Organs in EGFR-Mutated Stage IV NSCLC Patients Treated with First-Line Icotinib".JOURNAL OF THORACIC ONCOLOGY 16..3(2021):S420-S421

相关文献

[1]The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer. [2]YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations [3]表皮生长因子受体非热点突变型非小细胞肺癌一线应用表皮生长因子受体酪氨酸激酶抑制剂及化疗的疗效对比研究 [4]Afatinib overcoming resistance to icotinib and osimertinib in NSCLC with leptomeningeal metastasis in patients with acquired EGFR L858R/T790M or L858R/S768I mutations: Two case reports [5]Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer [6]The relationship between cerebrospinal fluid metastasis and gene mutations in non-small-cell lung cancer patients [7]Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study [8]A PROSPECTIVE, MOLECULAR EPIDEMIOLOGICAL STUDY OF EGFR MUTATIONS IN ASIAN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER WITH ADENOCARCINOMA HISTOLOGY (PIONEER STUDY) - CHINA SUBSET ANALYSIS [9]A prospective comparison study on EGFR mutations by direct sequencing and ARMS in completely resected Chinese non-small cell lung cancer with adenocarcinoma histology (ICAN) [10]Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis

资源点击量：39770 今日访问量：0 总访问量：1333 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持：重庆聚合科技有限公司 地址：河北省石家庄市健康路12号